What does a Mounjaro pen price actually include in the UK?

Free clinical consultation, reviewed the same day by a GPhC-registered Independent Prescriber
Prescription and treatment included — no separate dispensing or prescription fee
Free next-working-day tracked delivery via DPD, in plain unbranded packaging
Priority aftercare seven days a week, with clinical re-review before every repeat order

In the UK, the private price of a Mounjaro pen varies by dose and provider, typically ranging from roughly £149 to £375 per month since Eli Lilly raised its list price in September 2025. Every legitimate price must cover a valid prescription following clinical assessment — the pen alone is only part of the picture. Mounjaro (tirzepatide) is a prescription-only medicine, which means a qualified prescriber must assess your suitability before any treatment is dispensed. What you pay and what that payment actually covers can differ significantly between services, and understanding that gap is the most useful thing this page can give you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the pen price is only half the conversation, and what to look for

You've found a price online and you're not sure it adds up

This is where most people find themselves. You've searched, you've seen a range of figures, and something feels slightly off, either a number looks attractively low or you can't work out why two services are quoting very different amounts for what appears to be the same thing. That uncertainty is reasonable. Since Eli Lilly revised its UK list price from 1 September 2025, the highest-strength tirzepatide pen moved from around £122 to around £330 per four-week pen at list. Private services price above or around that depending on their cost base, so the market range of roughly £149–£375 per month is real, and it shifts by dose. You can read through a full breakdown of Mounjaro pen prices across doses if you want the specifics by strength.

The dose matters for the price of a Mounjaro pen specifically because treatment begins at 2.5mg (a starter dose whose job is to help your system adjust, not to deliver the full therapeutic effect) and is titrated upward by your prescriber over time. A lower-dose pen will cost less than a higher-dose one, so any quoted figure is only meaningful alongside which strength it refers to, and if you want to understand how much liquid is actually in a Mounjaro pen at each dose, that detail can help you make sense of what you're comparing. If a price seems fixed regardless of dose, that's worth querying.

The everyday reality: if you order by noon on a weekday, your prescription can be reviewed, approved if clinically suitable, and dispatched the same afternoon. Your pen arrives with DPD the next working day. That's the whole process, no waiting room, no waiting list.

What headline prices on comparison sites often leave out

The price of a Mounjaro pen as advertised is not always the price you pay. Some providers charge separately for the initial consultation, the written prescription, delivery, or follow-up clinical reviews. Others bundle everything into one figure. Without knowing which model you're looking at, two prices that appear to differ by £30 might actually be equivalent, or one might be £60 cheaper once all the extras are added back in.

Clinical aftercare is the piece most easily omitted from a headline price. Questions arise mid-treatment: a missed dose, a reaction, a question about whether to move to the next strength. If those conversations carry a charge, the total cost of treatment looks different over three or six months. The true cost of a Mounjaro pen across a full treatment course is a better figure to compare than the single-pen price.

Delivery is another variable. Free next-working-day delivery sounds standard, but not every service offers it. Some use economy postage; some charge for tracking. For a medicine that must be kept refrigerated, delivery method is also a safety consideration, not just a convenience one.

At nume, one price covers everything: consultation, prescription, treatment, and next-working-day tracked delivery. There are no subscriptions and no auto-renewals. Every repeat order is clinically re-reviewed before it goes out. We are not the cheapest option on the market, that is a deliberate choice, because the things that get stripped out to lower a price are the things that keep treatment safe.

Why the lowest Mounjaro pen price is the wrong target

For a prescription-only medicine, price is a poor proxy for value. The MHRA has warned repeatedly about fake weight-loss pens being sold online, some of which have been found to contain insulin rather than tirzepatide. In October 2025, the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided. Enforcement in 2025 alone resulted in the seizure of roughly 20 million doses of illegally traded weight-loss medicines, worth around £45 million. The sellers offering those products were, consistently, the ones with the most attractive prices and the least visible clinical infrastructure.

A legitimate service will hold a GPhC-registered pharmacy you can verify, nume's GPhC premises registration (9012878) is publicly searchable on the pharmacy register. It will conduct a real clinical assessment, supply genuine medicine through the licensed UK supply chain, and make a prescriber available if something goes wrong. None of that is free to provide, and it will not appear in the cheapest listing. The MHRA's public guidance on GLP-1 medicines sets this out plainly.

If you are weighing up options, the cheapest Mounjaro pen page covers the red flags to look for in more detail. The short version: a price far below the market range, a seller with no verifiable GPhC registration, or a route to treatment that requires no clinical assessment are all reasons to look elsewhere. Reporting suspect sellers via the MHRA's Yellow Card scheme is straightforward and genuinely useful.

For more on what Mounjaro is, how it works as a dual GIP and GLP-1 receptor agonist, and what the trial evidence shows, the Mounjaro overview page covers the clinical picture. If you have questions about how many injections come per month or want to check the 5mg pen price specifically, those pages go into the detail. When you're ready, start your free consultation and a prescriber will review your details the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions